Some Researchers Choose Replacement Over Repair in Aging
A new perspective in Aging Cell argues that replacing cells, tissues, or organs may be more feasible than repairing aged biology. It outlines biological and synthetic replacement strategies, from stem‑cell injections to bioprinted kidneys, and highlights a workshop that identified key hurdles such as immune rejection and age assimilation. The paper cites ongoing clinical trials at Wake Forest, vascularization work at Stanford, and genetic swaps inspired by long‑lived species. While speculative, the authors propose concrete research directions to make replacement‑based anti‑aging therapies viable.
Daytime Napping and Mortality Association in Older Adults
A JAMA Network Open study of 1,338 older adults used wrist actigraphy to objectively measure daytime napping patterns and found that longer nap duration and higher nap frequency are linked to increased all‑cause mortality. Each additional hour of napping adds...
A Robust Senescence Response Helps Wounds Heal
Scientists compared wound healing in young (2‑month) and old (24‑month) mice and found that a rapid, temporary surge of senescent cells in the young animals accelerates closure. The younger mice displayed sharp up‑regulation of senescence markers p16, p21 and SA‑β‑gal,...
Reprogrammed Cardiomyocytes Soften the Blow in Heart Attack
A recent study published in the Journal of Molecular and Cellular Cardiology demonstrates that partial reprogramming of mouse cardiomyocytes with three Yamanaka factors (OCT4, SOX2, KLF4 – OSK) enables the cells to complete cytokinesis after a heart attack. By dismantling...
Rapamycin Might Blunt Exercise Response in Humans
A double‑blind, placebo‑controlled trial gave 40 sedentary adults aged 65‑85 a weekly 6 mg dose of rapamycin alongside a 13‑week home‑based exercise program. Participants receiving rapamycin showed smaller gains in chair‑stand performance and trended worse on six‑minute walk and grip strength,...
BioAge Reports Positive Phase 1 Data for BGE-102
BioAge Labs announced Phase 1 results for BGE‑102, an oral, brain‑penetrant NLRP3 inhibitor, showing up to 86% reductions in high‑sensitivity C‑reactive protein (hsCRP) in obese participants. A 60 mg once‑daily regimen over 21 days achieved biomarker improvements comparable to the previously tested...
Targeting an Appetite Hormone Receptor for Stronger Muscles
Researchers published in Aging Cell that suppressing the ghrelin receptor (GHSR‑1a) improves muscle performance and mitigates sarcopenia in aged mice. Genetic knockout of GHSR‑1a extended running endurance by up to 45% and reduced muscle fatigue, while preserving mitochondrial function through...
Vitamin C Alleviates Aging in Cynomolgus Monkeys
Researchers introduced the term “ferro‑aging” to describe iron‑driven lipid peroxidation that accelerates cellular senescence. They showed that excess iron elevates ACSL4, boosting reactive oxygen species and aging markers in cells, mice and cynomolgus monkeys. A high‑throughput screen identified vitamin C as...
Life Bio’s Trial: Is the FDA Warming to Rejuvenation?
Life Biosciences received FDA clearance for its ER-100 investigational new drug, marking the first human trial of a cellular reprogramming therapy aimed at the eye. The Phase 1 study will enroll patients with glaucoma or non‑arteritic anterior ischemic optic neuropathy, emphasizing...
The Timing of Meals Matters for Biological Aging
A new analysis of 14,012 NHANES participants links meal timing to biological aging. Later first meals, later last meals, and feeding windows longer than 16 hours correlate with faster aging of the whole body, heart, liver and kidneys. The optimal window...
A Target for Ameliorating Post-Operative Delirium
Researchers identified the chromatin remodeler RUVBL2 as a key driver of metabolic reprogramming in microglia that underlies post‑operative delirium in aged rats. Suppressing RUVBL2 reversed the glycolytic shift, boosted ATP production, reduced stress‑granule accumulation, and restored performance on Barnes maze...
Modified Immune Cells Target Cancer’s Metabolic Signature
Stanford researchers engineered natural killer (NK) and cytotoxic T cells to overexpress metabolite‑sensing G protein‑coupled receptors, most notably GPR183, enabling the cells to home toward tumor‑derived metabolic cues. In mouse models of triple‑negative breast and ovarian cancer, GPR183‑enhanced NK‑92 cells...
How a Growth Factor and SIRT1 Might Combat Disc Degeneration
Researchers reported that administering the metabolic hormone FGF21 boosts SIRT1 expression, which in turn activates the PINK1‑Parkin mitophagy pathway and reduces cellular senescence in intervertebral disc cells. In a rat model of puncture‑induced disc degeneration, FGF21 treatment partially restored nucleus...
Rubedo Announces Positive Preliminary Results for RLS-1496
Rubedo Life Sciences reported positive preliminary Phase 1 data for RLS‑1496, the first human‑tested GPX4 modulator designed to clear senescent cells. The 4‑week, double‑blind study in the EU showed the drug was well‑tolerated, produced a clear dose‑response, and reduced epidermal thickness...
Mitochondria Delivery Method Rescues Parkinson’s in Mice
Scientists have engineered red‑blood‑cell membrane capsules to ferry healthy mitochondria into diseased cells, dramatically improving delivery efficiency. In vitro, the capsules restored mitochondrial function in mtDNA‑deficient and mutant fibroblasts, reducing pathogenic DNA fractions and boosting ATP production. In vivo, mice...